|Articles|June 1, 2001

The American Journal of Managed Care

  • June 2001
  • Volume 7
  • Issue 6

Effect of Rofecoxib Therapy on Measures of Health-Related Quality of Life in Patients with Osteoarthritis

Download PDF: Effect of Rofecoxib Therapy on Measures of Health-Related Quality of Life in Patients with Osteoarthritis

Articles in this issue

over 24 years ago

Health Plan's Use of Asthma Quality Improvement Projects to Meet NCQA Accreditation Standards

over 24 years ago

Does the HEDIS Asthma Measure Go Far Enough?

over 24 years ago

Diagnosis and Care of Irritable Bowel Syndrome in a Community-Based Population

over 24 years ago

Prevalence and Determinants of Osteoporosis Drug Prescription Among Patients with High Exposure to Glucocorticoid Drugs

over 24 years ago

Rheumatoid Arthritis: Guidelines for Emerging Therapies

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs
Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

View more
Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care
AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

View more
Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text